High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
- 25 October 2000
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 36 (5), 1587-1593
- https://doi.org/10.1016/s0735-1097(00)00912-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failureThe American Journal of Cardiology, 1995
- Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failureJournal of the American College of Cardiology, 1994
- Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure.Circulation, 1992
- Neuroendocrine activity in untreated heart failure.Heart, 1991
- Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?Annals of Internal Medicine, 1991
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Prognostic importance of atrial natriuretic peptide in patients with chronic heart failureJournal of the American College of Cardiology, 1989
- Neurohormonal interactions and adaptations in congestive heart failure.Circulation, 1988
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- The Neurohumoral Axis in Congestive Heart FailureAnnals of Internal Medicine, 1984